Yourgene Health PLC (LSE:YGEN) - Share price


Stock Report

Yourgene Health PLC YGEN

Last Price
GBX12.01

Day Change
0.38|3.27%

As of 19/07/2019
10:45:44 BST | GBX
Minimum 15 Minutes Delay.

Last Close11.63p
Day Range11.65 - 12.01
Mkt Cap69.63Mil
52-Wk Range6.42 - 14.45
Yield %-
ISINGB00BN31ZD89
Volume777,695
P/E13.64
P/S0.05
P/CF-0.12

Share Price

Total Returns 18/07/2019

 Chg (%)  
More ...
Yourgene Health PLC-10.58 
FTSE 100 TR GBP0.81
 
Financials
201720182019
More ...
Income Statement
Turnover3.086.158.88
Operating Profit-6.91-5.90-4.66
Net Profit-7.86-9.483.39
Reported EPS-3.00-2.950.85
Balance Sheet
Current Assets6.124.275.30
Non Current Assets11.4410.3210.30
Total Assets17.5614.5915.60
Current Liabilities6.944.644.25
Total Liabilities---
Total Equity5.85-2.6010.70
Cash Flow
Operating Cash Flow-7.86-9.60-4.04
Net Change in Cash-4.04-1.020.97
Director Dealings
TradedActionNotifierPriceAmountValue
More ...
31/05/2019PurchaseMr. Adam Reynolds11.00900,00099,000.00
09/05/2019PurchaseDr. Stephen Little11.20448,45250,227.00
08/05/2019PurchaseBarry Kenneth Hextall11.5089,55110,298.00
08/05/2019PurchaseMr. Hayden Jeffreys11.50222,34825,570.00

Company Profile

Premaitha Health PLC is a molecular diagnostics company. The company has developed IONA test that enables clinical laboratories to establish a routine, quality assured non-invasive prenatal screening service in-house.

Sector

Diagnostics & Research

Index

FTSE AIM All-Share

Next Event 30/09/2019

Annual General Meeting
Ratios
Comp
More ...
PER (E)0.00
Div Yld (E)0.00
PEG (E)0.00
ROCE40.53
Op Mrgn-0.53
EPS Grwth0.00
Dividends
PreviousLatest
More ...
Record Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00
Directors
More ...
Non-Executive Director, ChairmanMr. Adam Reynolds
Executive Director, Chief Financial Officer and Company SecretaryBarry Kenneth Hextall
Non-Executive Director, Senior Independent DirectorMr. Nicholas Mustoe
Executive Director, Vice ChairmanDr. Stephen Little
Executive Director, Chief Operating OfficerMr. Hayden Jeffreys
Executive Director, Chief Scientific OfficerDr. Chia-Han Bill Chang
Executive Director, Chief Executive OfficerMr. Lyn Fafydd Rees
Executive Director, Chief Operating Officer, AsiaMr. Keng Hou Hsu
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2019 Morningstar. All rights reserved.